Aguilar DA, Lacy NRM, Hajar T

Idioma: Español
Referencias bibliográficas: 42
Paginas: 128-133
Archivo PDF: 152.51 Kb.

RESUMEN

El objetivo de este artículo es dar a conocer los riesgos de la fototerapia y la fotoquimioterapia (puva); qué modalidades se pueden usar, como uvb-be o láser excímero 308 nm y se revisa la literatura para otras modalidades terapéuticas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Anstey, A. y Trautinger, F., “The art and science of photodermatology beyond the surface of the skin”, Photochem Photobiol Sci, 2013, 12 (1): 13-15.

2. Carrascosa, J.M., “Fototerapia y fotoquimioterapia”, Actas Dermosifilogr, 2004, 95: 259-284.

3. Tan, E., Lim, D. y Rademaker, M., “Narrowband uvb phototherapy in children: A New Zealand experience”, Australas J Dermatol, 2010, 51 (4): 268-273.

4. Lee, C.H., Wu, S.B., Hong, C.H., Yu, H.S. y Wei, Y.H., “Molecular Mechanisms of uv-Induced Apoptosis and its Effects on Skin Residential Cells: The Implication in uv-Based Phototherapy”, Int J Mol Sci, 2013, 14 (3): 6414-6435.

5. Bae, Y.-S.C., Van Voorthees, A.S., Hsu, S., Korman, N.J., Lebwohl, M.G., Young, M. et al., “Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation”, J Am Acad Dermatol, 2012, 67: 459-477.

6. Garmyn, M. y Yarosh, D.B., “The Molecular and Genetic Effects of Ultraviolet Radiation Exposure on Skin Cells”, en Lim, H.W., Hönigsmann, H. y Hawk, J.L.M., Photodermatology, Londres, Informa Healthcare, 2007, 41-54.

7. Yoon, J.H., Lee, C.S., O’Connor, T.R., Yasui, A. Pfeifer, G.P., “The dna damage spectrum produced by simulated sunlight”, J Mol Biol, 2000, 299: 681-693.

8. Park, K. y Murase, J., “Narrowband uv-b Phototherapy During Pregnancy and Folic Acid Depletion”, Arch Dermatol, 2012, 148 (1): 132-133.

9. El-Saie, L.T., Rabie, A.R., Kamel, M.I., Seddeik, A.K. y Elsaie, M.L., “Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis”, Laer Med Sci, 2011, 26 (4): 481-485.

10. Morison, W.L. y Richard, E.G., “puva phototherapy and other phototherapy modalities”, en Wolverton, S.E., Comprehensive Dermatologic Drug Therapy, Filadelfia, Saunders Elsevier, 2013, 279-290.

11. Krutmann, J., Morita, A. y Elmets, C.A., “Mechanisms of Photo(chemo) therapy”, en Krutmann, J., Hönigsmann, H. y Elmets, C.A., Dermatological Phototherapy and Photodiagnostic Methods, Berlín-Nueva York, Springer- Verlag, 2001, 54-68.

12. Stern, R.S. y Lange, R., “Outcomes of Pregnancies Among Women and Partners of Men with a History of Exposure to Methoxsalen Photochemotherapy (puva) for The Treatment of Psoriasis”, Arch Dermatol, 1991, 127: 347-350.

13. Gunnarskog, J.G., Kallen, A.I., Lindelof, B.G. y Sigurgeirsson, B., “Psoralen photochemotherapy (puva) and pregnancy”, Arch Dermatol, 1993, 129: 320-323.

14. Menter, A., Korman, N.J., Elmets, C.A., Feldman, S.R., Gelfland, J.M., Gordon, K.B. et al., “Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy”, J Am Acad Dermatol, 2010, 62: 114-135.

15. Lee, K.B. y Leachman, S.A., “Dermatologic drugs during pregnancy and lactation”, en Wolverton, S.E., Comprehensive Dermatologic Drug Therapy, Filadelfia, Saunders Elsevier, 2013, 718-729.

16. American Academy of Dermatology Committee on Guidelines of Care, “Guidelines of care for Psoriasis”, J Am Acad Dermatol, 1994, 31: 643-648.

17. Halpern, S.M., Anstey, A.V., Dawe, R.S., Diffey, B.L., Farr, P.M., Ferguson, J. et al., “Guidelines for topical puva: a report of a workshop of the British Photodermatology Group”, British Journal of Dermatology, 2000, 142: 22-31.

18. Furuhashi, T., Saito, C., Torii, K., Nishida, E., Yamazaki, S. y Morita, A., “Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis”, PloS One, 2013, 8 (1): e54895.

19. Salo, O., Lassus, A. y Taskinen, J., “Trioxsalen bath plus uva treatment of psoriasis. Plasma concentration of the drug and clinical results”, Acta Derm Venereol, 1981, 61: 551-554.

20. Von Kobyletzki, G., Hoffmann, K., Kerscher, M. y Altmeyer, P., “Plasma levels of 8-methoxypsoralen following puva-bath photochemotherapy”, Photodermatol Photoimmunol Photomed, 1998, 14 (3-4): 136-138.

21. Fischer, T., Hartvig, P. y Bondesson, U., “Plasma concentrations after bath treatment and oral administration of trioxsalen”, Acta Derm Venereol, 1980, 60(2): 177-179.

22. Kappes, U.P., Barta, U., Merkel, U., Balogh, A. y Elsner, P., “High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients”, Skin Pharmacol Appl Skin Physiol, 2003, 16 (5): 305-312.

23. Tewari, A., Grage, M.M., Harrison, G.I., Sarkany, R. y Young, A.R., “uva1 is skin deep: molecular and clinical implications”, Photochem Photobiol Sci, 2013, 12 (1): 95-103.

24. Jabara, B., Dahlgren, M. y McGrath, H., Jr., “Interstitial lung disease and pulmonary hypertension responsive to low-dose ultraviolet A1 irradiation in lupus”, J Clin Rheumatol, 2010, 16(4): 188-189.

25. Feldmeyer, L., Shojaati, G., Spanaus, K.S., Navarini, A., Theler, B., Donghi, D. et al., “Phototherapy with uvb narrowband, uva/uvbnb, and uva1 diflaferentially impacts serum 25-hydroxyvitamin-D3”, J Am Acad Dermatol, 2013; 69 (4): 530-536.

26. Zandi, S., Kalia, S. y Lui, H., “uva1 phototherapy: a concise and practical review”, Skin Therapy Lett, 2012, 17 (1): 1-4.

27. Carrascosa, J.M., López-Estebaranz, J.L., Carretero, G., Daudén, E., Ferrándiz, C., Vidal, D. et al., “Documento de consenso de fototerapia en psoriasis del Grupo Español de Psoriasis: ultravioleta B de banda estrecha (uvbbe), láser y fuentes monocromáticas de excímeros y terapia fotodinámica”, Actas Dermatosifiliogr”, 2011, 102 (3): 175-186.

28. Jang, M.S., Baek, J.W., Kang, D.Y., Kang, J.S., Kim, S.T. y Suh, K.S., “Successful treatment with narrowband uvb phototherapy in prurigo pigmentosa associated with pregnancy”, Eur J Dermatol, 2011, 21 (4): 634-635.

29. Zeicher, J.A., “Narrowband uv-b phototherapy for the treatment of acne vulgaris during pregnancy”, Arch Dermatol, 2011, 147 (5): 537-539.

30. Vun, Y.Y., Jones, B., Al-Mudhaffer, M. y Egan, C., “Generalized pustular psoriasis of pregnancy treated with narrowband uvb and topical steroids”, J Am Acad Dermatol, 2006, 54 (2 Suppl): S28-30.

31. Tauscher, A.E., Fleischer, A.B., Jr, Phelps, K.C. y Feldman, S.R.J., “Psoriasis and pregnancy”, Cutan Med Surg, 2002, 6 (6): 561-570.

32. Branda, R.F. y Eaton, J.W., “Skin color and nutrient photolysis; an evolutionary hypothesis”, Science, 1978, 201: 625-626.

33. Shaheen, M.A., Abdel Fattah, N.S. y El-Borhamy, M.I., “Analysis of serum folate levels after narrow band uvb exposure”, Egypt Dermatol Online J, 2006, 2: 13.

34. Juzeniene, A., Stokke, K.T., Thune, P. y Moan, J., “Pilot study of folate status in healthy volunteers and in patients with psoriasis before and after uv exposure”, J Photochem Photobiol B, 2010, 101 (2): 111-116.

35. Wiwanitkit, V., “Narrowband ultraviolet B phototherapy and serum folic acid level”, Lasers Med Sci, 2012, 27 (3): 685.

36. Rose, R.F., Batchelor, R.J., Turner, D. y Goulden, V., “Narrowband ultraviolet B phototherapy does not influence serum and red cell folate levels in patients with psoriasis”, J Am Acad Dermatol, 2009, 61 (2): 259-262.

37. Braathen, L.R., Szeimies, R.M., Basset-Seguin, N., Bissonnette, R., Foley, P., Pariser, D. et al., “International Society for Photodynamic Therapy in Dermatology Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus”, 2005, J Am Acad Dermatosl, 2007, 56 (1): 125-143.

38. Yang, Y.G., Zou, X.B., Zhao, H., Zhang, Y.J. y Li, H.J., “Photodynamic therapy of therapy of condyloma acuminata in pregnant women”, Chin Med J, 2012, 125 (16): 2925-2928.

39. Liebmann, J., Born, M. y Kolb-Bachofen, V., “Blue-light irradiation regulates proliferation and differentiation in human skin cells”, J Invest Dermatol, 2010, 130 (1): 259-269.

40. Kong, Y.L. y Tey, H.L., “Treatment of acne vulgaris during pregnancy and lactation”, Drugs, 2013, 73 (8): 779-787.

41. Richards, E.M. y Payne, J.L., “The management of mood disorders in pregnancy: alternatives to antidepressants”, cns Spectr, 2013, 10: 1-11 [Epub ahead of print].

42. Wilson, J.H., Sinaasappel, M., Lotgering, F.K. y Langendonk, J.G., “Recommendations for pregnancies in patients with crigler-najjar syndrome”, jimd Rep, 2013, 7: 59-62.